![Xavier Matias-Guiu Guia](/media/upload/cache/129949_a115x115.jpg)
Xavier Matias-Guiu Guia
Degree: PhD
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Groups
Publications
-
Gallardo, A; Matias-Guiu, X; Lagarda, H; Catasus, L; Bussaglia, E; Gras, E; Suarez, D; Prat, J
Malignant mullerian mixed tumor arising from ovarian serous carcinoma: a clinicopathologic and molecular study of two cases
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 21 268-272. .
-
Sabate, JM; Gomez, A; Torrubia, S; Matias-Guiu, X; Alonso, C; Pericay, C; Diaz, O
Microglandular adenosis of the breast in a BRCa1 mutation carrier: radiological features
EUR RADIOL 12 1479-1482. .
-
Llauger, J; Bague, S; Palmer, J; Matias-Guiu, X; San Roman, L; Doncel, A
Focal myositis of the thigh: unusual MR pattern
SKELETAL RADIOL 31 307-310. .
-
Bussaglia, E; Pujol, RM; Gil, MJ; Marti, RM; Tuneu, A; Febrer, MI; Garcia-Patos, V; Ruiz, EM; Barnadas, M; Alegre, M; Serrano, S; Matias-Guiu, X
PTEN mutations in eight Spanish families and one Brazilian family with Cowden syndrome.
JOURNAL OF INVESTIGATIVE DERMATOLOGY 118 639-644. .
-
Muret, MPG; Puig, L; Pujol, RM; Matias-Guiu, X; Alomar, A
Non-congenital smooth muscle hamartoma: 3 cases
ANN DERMATOL VENER 129 417-420. .
-
Machin, P; Catasus, L; Pons, C; Munoz, J; Matias-Guiu, X; Prat, J
CTNNB1 mutations and beta-catenin expression in endometrial carcinomas
HUMAN PATHOLOGY 33 206-212. .
-
Gras, E; Catasus, L; Arguelles, R; Moreno-Bueno, G; Palacios, J; Gamallo, C; Matias-Guiu, X; Prat, J
Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors
CANCER 92 2829-2836. .
[doi:10.1002/1097-0142(20011201)92:11<2829::AID-CNCR10094>3.0.CO;2-3]
-
Matias-Guiu, X; Prat, J
Tumor invasion and metastasis - Nature or nurture? Reply
HUMAN PATHOLOGY 32 1416-1416. .
-
Rodriguez, I; Ayala, E; Caballero, C; De Miguel, C; Matias-Guiu, X; Cubilla, AL; Rosai, J
Solitary fibrous tumor of the thyroid gland - Report of seven cases
AMERICAN JOURNAL OF SURGICAL PATHOLOGY 25 1424-1428. .
-
Domingo, P; Matias-Guiu, X; Pujol, RM; Domingo, JC; Arroyo, JA; Sambeat, MA; Vazquez, G
Switching to nevirapine decreases insulin levels but does not improve subcutaneous adipocyte apoptosis in patients with highly active antiretroviral therapy-associated lipodystrophy
JOURNAL OF INFECTIOUS DISEASES 184 1197-1201. .
-
Gras, E; Pons, C; Machin, P; Matias-Guiu, X; Prat, J
Loss of heterozygosity at the RB-1 locus and pRB immunostaining in epithelial ovarian tumors: a molecular, immunohistochemical, and clinicopathologic study
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 20 335-340. .
-
Gras, E; Cortes, J; Diez, O; Alonso, C; Matias-Guiu, X; Baiget, M; Prat, J
Loss of heterozygosity on chromosome 13q12-q14, BRCa-2 mutations and lack of BRCa-2 promoter hypermethylation in sporadic epithelial ovarian tumors
CANCER 92 787-795. .
[doi:10.1002/1097-0142(20010815)92:4<787::AID-CNCR1384>3.0.CO;2-4]
Projects
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU